EVERSANA announced three appointments to the company’s executive leadership team.
Augmented reality (AR) gained widespread attention the summer of 2016 with the addictive game Pokémon Go. But these days, AR is not just for fun. This disruptive technology is expected to drive significant changes to businesses across many industries because of its ability to combine the virtual and physical worlds.
Report Shows Life Science Companies Continue to Be a Favorite Target of Securities Fraud Class Action Lawsuits
Despite a decline over the past year of class action lawsuits, life science companies remain a popular target for securities fraud litigation.
Megaputer Intelligence is hosting a series of live webinars related to data analysis applications for pharmaceutical and life sciences companies beginning on February 6, 2019, and continuing weekly through April 2019.
FreshBlood Health Market Consultants, which was launched in 2015 by prominent healthcare industry marketing expert Robert Finkel, announced the life-science solutions provider’s expanded creative services capabilities and official reconfiguration as FreshBlood Group.
EVERSANA unveiled Health Strategies Insights by EVERSANA, a comprehensive market access research and insights portfolio to help life science innovators make more informed decisions.
JLL’s life sciences experts anticipate that Big Pharma during 2019 will adopt agile real estate strategies and more entrepreneurial approaches to reinvent R&D and compete with smaller enterprises that are doubling down on product innovation and delivery.
Audacity Health LLC, a premier brand strategy and activation agency for health and life sciences, announced the grand opening of a new Boston office location.
BioSpace presented the NextGen Bio “Class of 2019,” a list of 20 up-and-coming life science companies in North America that launched no earlier than 2017. According to BioSpace, the companies are already making an enormous impact on the industry and will continue to do so into the future.
Here is a look at BioSpace’s top 10 stories of 2018.
Paris-based Sanofi signed the lease on two buildings yet to be built in East Cambridge, Massachusetts. Sanofi is the state’s largest life science employer and plans to shift 2,700 staffers into the two buildings at Cambridge Crossing.